The Molecular Basis of Disorders Caused by Defects in G Proteins

Hormone Research in Paediatrics

Volumn 47, Issue 3, 1997, Pages 89-96

  Spiegel, Allen M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

G protein coupled receptors; GTPase; Mutations; Signal transduction

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR;

ACROMEGALY; ALBRIGHT SYNDROME; ARTICLE; GENE MUTATION; GERM LINE; HUMAN; METABOLISM; PRIORITY JOURNAL; PROTEIN DEFECT; PSEUDOHYPOPARATHYROIDISM; SECOND MESSENGER; SIGNAL TRANSDUCTION; THYROID NODULE;

EID: 0031044662     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185441     Document Type: Article

References (28)

1. Spiegel AM, Jones TLZ, Simonds WF, Weinstein LS: G Proteins. Austin. Landes. 1994.
2. Wall MA, Coleman DE, Lee E, Inigucz-Lluhi JA, Posner BA, Gilman AG, Sprang SR: The structure of the G protein hetcrotrimer Gu, ilV- Cel1 1995:83:1047-1058.
3. Neer EJ: Helerotrimeric G proteins: Organizers of transmembrane signals. Cell 1995:80: 249-257.
4. Spiegel AM: Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 1996;58:143-170.
5. Spiegel AM: Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996:81:2434-2442.
6. Strader CD. Fong TM. Tota MR. Underwood D: Structure and function of G protein-coupled receptors. Annu Rev Biochcm 1994:63:101-132.
7. Iismaa TP, Bidcn TJ, Shine J: G Protein-Coupled Receptors. Austin. Landes. 1995.
8. Berman DM. Wilkie TM. Gilman AG: GAIP and RGS4 are GTPase-activating proteins for the G, subfamily of G protein a subunits. Cell 1996:86:445-452.
9. su gene (GNASI) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 1995;4:2001-2002.
10. Schwindinger WF, Mitric A, Zimmerman D, Levine MA: A novel Gsu mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenvlyl cyclase. J Biol Chem 1994:269:25387-2539.
11. Farfcl Z. Liri T. Shapira H. Roitman A. Moual-lem M. Bourne HR: Pseudohypoparathyroidism. a novel mutation in the Py-contact region of G„a impairs receptor stimulation. J Biol Chem 1996;271:19653-19655.
12. Davies SJ. Hughes HE: Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30:101-103.
13. sa in patients with gain and loss of endocrine function. Nature 1994:371:164-168.
14. Spada A, Vallar L, Faglia G: G protein oncogenes in pituitary tumors. Trends Endocrinol Metab 1992;3:355-360.
15. Landis CA. Masters SB. Spada A. Pace AM. Bourne HR. Vallar L: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylvl cyclase in human pituitary tumours. Nature 1989:340:692-696.
16. Coleman DF, Berghuis AM, Lee E, Linder ME, Gilman AG, Sprang SR: Structures of active conformations of G,„i and the mechanism of GTP hydrolysis. Science 1994;265:1405-1412.
17. Lyons J, Landis CA, Harsh G, Vallar L, Griine-wald K, Fcichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 1990:249:655-659.
18. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumbergcr M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S: Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1995:80:1347-1351.
19. Reincke M, Karl M, Travis W, Chrousos GP: No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab 1993:77:1419-1422.
20. Dumont JE. Jauniaux JC. Roger PP: The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 1989:14:67-71.
21. Weinstein IS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM: Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-1695.
22. su mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994:79:750-755.
23. Shenker A, Weinstein LS, Moran A, Pescovilz OH, Charcsl NJ, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM: Severe endocrine and non-endocrine manifestations of the McCune-Albrighl syndrome associated with activating mutations of the stimulatory G protein, Gs. J Pediatr 1993:123:509-518.
24. Dryja TP. I lahn LB. Reboul T. Arnaud B: Mis-sense mutation in the gene encoding the u subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet 1996:13:358-360.
25. Feuillan PP. Jones J. Ross JL: Growth hormone hypersecretion in a girl with McCune-Albright syndrome: Comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 1995: 80:1357-1360.
26. Dong Q. Brucker-Davis F. Weintraub BD. Smallridge RC. Carr FE. Batley J. Spiegel AM. Shenker A: Screening of candidate oncogenes in human thyrotroph tumors: Absence of activating mutations of the Galpha-q. Galpha-11. Galpha-s, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab 1996: 81:1134-1140.
27. Dhanasckaran N. Heasley LE. Johnson GL: G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev 1995: 16:259-270.
28. Rudclph U. Fincgold MJ. Rich SS. Harriman GR. Srinavasan Y. Brabct P. Boulay G: Ulcerative colitis and adenocarcinoma of the colon in Galpha-i2-dcficicnt mice. Nat Genet 1995: 10:143-150.